Connection

Kimme Hyrich to Follow-Up Studies

Back to Details
This is a "connection" page, showing publications Kimme Hyrich has written about Follow-Up Studies.
Kimme Hyrich
Connection Strength
0.110
Follow-Up Studies
  1. Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Rheumatology (Oxford). 2018 09 01; 57(9):1533-1540.
    View in: PubMed
    Score: 0.049
  2. The predictors of and reasons for non-adherence in an observational cohort of patients with rheumatoid arthritis commencing methotrexate. Rheumatology (Oxford). 2020 01 01; 59(1):213-223.
    View in: PubMed
    Score: 0.013
  3. Opportunistic infections in rheumatoid arthritis patients exposed to biologic therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Rheumatology (Oxford). 2018 06 01; 57(6):997-1001.
    View in: PubMed
    Score: 0.012
  4. Long-term persistence with rituximab in patients with rheumatoid arthritis. Rheumatology (Oxford). 2018 06 01; 57(6):1089-1096.
    View in: PubMed
    Score: 0.012
  5. The relationship between depression and biologic treatment response in rheumatoid arthritis: An analysis of the British Society for Rheumatology Biologics Register. Rheumatology (Oxford). 2018 05 01; 57(5):835-843.
    View in: PubMed
    Score: 0.012
  6. Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Ann Rheum Dis. 2018 06; 77(6):905-910.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.